Cardinal Health raised its annual outlook again after logging higher profit and revenue in its fiscal second quarter.

The team remains focused on driving Cardinal Health brand growth, where we continue to see positive results and ...

The pharmaceutical distributor and health services company raises its guidance for the second time.

Cardinal Health has reported that revenue for its Other segment, which includes at-Home Solutions, increased 34% to $1.7 billion for its second quarter fiscal year 2026. Profit for ...

Cardinal Health CEO Jason Hollar talked to us about how the Dublin HQ and Columbus-area warehouses help drive sales, profits ...

Cardinal Health (CAH) upgraded to Buy after strong Q2 FY2026 results, higher guidance, and $750M buybacks. Read here for more ...

Pharmaceutical distributor Cardinal Health is eyeing an expanded footprint in the specialty medicine space through the planned acquisitions of GI Alliance (GIA) and Advanced Diabetes Supply Group (DSG ...

Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.

Cardinal Health reports strong Q2 results and raises fiscal 2026 outlook. Sales increased by 19%, beating estimates.

Cardinal Health (NYSE: CAH) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, ...

The Columbus Zoo and Aquarium has appointed Stacey Burbure of AEP and Jessica Mayer of Cardinal Health to its board, adding ...

Target, CVS and Rite Aid are pulling products from shelves after federal investigators found unsanitary conditions and recommended a recall. By Rebecca Carballo An agreement between attorneys general ...